Steven R. Alberts

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database”.

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Annals of Oncology(2020)10.1016/j.annonc.2019.12.007

N/A

1.4DataRank · unranked

34 citations

Jun Yin, Richard M. Goldberg, Levi Pederson, Norman Wolmark, Steven R. Alberts +11 more

Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]

Annals of Oncology(2022)10.1016/j.annonc.2022.07.1942

N/A

1.1DataRank · unranked

27 citations

Nathan R. Foster, Hye‐Eun Lee, Q. Shi, Steven R. Alberts, Thomas C. Smyrk +2 more

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0.330DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1274

N/A

0.216DataRank · unranked

2 citations

Xinwei Hua, Tabitha A. Harrison, Barbara L. Banbury, Jeroen R. Huyghe, Wei Sun +13 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab070

N/A

0DataRank · unranked

9 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1848

N/A

0DataRank · unranked

10 citations

James Y. Dai, Sara Lindström, Tabitha A. Harrison, Yi Lin, Steven R. Alberts +29 more

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)

Investigational New Drugs(2021)10.1007/s10637-021-01090-w

N/A

0DataRank · unranked

10 citations

Nathan R. Foster, Amit Mahipal, Thomas Byrne, Joleen M. Hubbard, Alvin Silva +4 more

Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3591

N/A

0DataRank · unranked

1 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0320

N/A

0DataRank · unranked

4 citations

Dominic Edelmann, Federico Canzian, Tabitha A. Harrison, Xinwei Hua, Qian Shi +11 more

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

Cancer Control(2023)10.1177/10732748231185047

N/A

0DataRank · unranked

7 citations

Joleen M. Hubbard, Paul J. Novotny, Megan E. Branda, Daniel S. Sargent, Roscoe F. Morton +8 more

Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients

International Journal of Cancer(2023)10.1002/ijc.34663

N/A

0DataRank · unranked

4 citations

Dominic Edelmann, Federico Canzian, Petra Seibold, Tabitha A. Harrison, Xinwei Hua +14 more

Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4099

N/A

0DataRank · unranked

1 citations

Jesse G. Dixon, Hiral D. Parekh, Steven R. Alberts, Greg Yothers, Carmen J. Allegra +15 more

Tumor-infiltrating lymphocytes and tumor budding refine prognostication in patients with low- and high-risk stage III colon cancers (NCCTG N0147)[Alliance].

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4065

N/A

0DataRank · unranked

0 citations

Hee Eun Lee, Nathan R. Foster, Qian Shi, Steven R. Alberts, Thomas C. Smyrk +2 more

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

UNC Libraries(2020)10.17615/23jw-by02

N/A

0DataRank · unranked

0 citations

Qian Shi, Axel Grothey, Jan Franko, Richard M. Goldberg, Daniel J. Sargent +5 more